Clinical Trials Browser

Phase 2 × Brain Neoplasms × Opdualag × Clear all

NCT06712927 2026-05-18

Trial of Relatlimab, Nivolumab, and Ipilimumab in Patients With Asymptomatic and Symptomatic Melanoma Brain Metastases

Phase 2 Recruiting

CNSDermatologic

Brain Neoplasms, Melanoma